OBJECTIVE—: Cyclic AMP responsive element–binding protein 3–like 3 (CREB3L3) is a novel candidate gene for dominant hypertriglyceridemia. To date, only 4 kindred with dominant hypertriglyceridemia have been found to be carriers of 2 nonsense mutations in CREB3L3 gene (245fs and W46X). We investigated a family in which hypertriglyceridemia displayed an autosomal dominant pattern of inheritance. APPROACH AND RESULTS—: The proband was a 49-year-old woman with high plasma triglycerides (≤1300 mg/dL; 14.68 mmol/L). Her father had a history of moderate hypertriglyceridemia, and her 51-year-old brother had triglycerides levels as high as 1600 mg/dL (18.06 mmol/L). To identify the causal mutation in this family, we analyzed the candidate genes of recessive and dominant forms of primary hypertriglyceridemia by direct sequencing. The sequencing of CREB3L3 gene led to the discovery of a novel minute frame shift mutation in exon 3 of CREB3L3 gene, predicted to result in the formation of a truncated protein devoid of function (c.359delG–p.K120fsX20). Heterozygosity for the c.359delG mutation resulted in a severe phenotype in the proband, and her brother with a late in life expression and a good response to diet and a hypotriglyceridemic treatment. The same mutation was detected in a 13-year-old daughter who to date is normotriglyceridemic. CONCLUSIONS—: We have identified a novel pathogenic mutation in CREB3L3 gene in a family with dominant hypertriglyceridemia with a variable pattern of penetrance.

Cefalù, A., Spina, R., Noto, D., Valenti, V., Ingrassia, V., Giammanco, A., et al. (2015). Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 35(12), 2694-2699 [10.1161/ATVBAHA.115.306170].

Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia

CEFALU', Angelo Baldassare;SPINA, Rossella;NOTO, Davide;VALENTI, Vincenza;Ingrassia, Valeria;Giammanco, Antonina;PANNO, Maria Donata;GANCI, Antonina;BARBAGALLO, Carlo Maria;AVERNA, Maurizio
2015-01-01

Abstract

OBJECTIVE—: Cyclic AMP responsive element–binding protein 3–like 3 (CREB3L3) is a novel candidate gene for dominant hypertriglyceridemia. To date, only 4 kindred with dominant hypertriglyceridemia have been found to be carriers of 2 nonsense mutations in CREB3L3 gene (245fs and W46X). We investigated a family in which hypertriglyceridemia displayed an autosomal dominant pattern of inheritance. APPROACH AND RESULTS—: The proband was a 49-year-old woman with high plasma triglycerides (≤1300 mg/dL; 14.68 mmol/L). Her father had a history of moderate hypertriglyceridemia, and her 51-year-old brother had triglycerides levels as high as 1600 mg/dL (18.06 mmol/L). To identify the causal mutation in this family, we analyzed the candidate genes of recessive and dominant forms of primary hypertriglyceridemia by direct sequencing. The sequencing of CREB3L3 gene led to the discovery of a novel minute frame shift mutation in exon 3 of CREB3L3 gene, predicted to result in the formation of a truncated protein devoid of function (c.359delG–p.K120fsX20). Heterozygosity for the c.359delG mutation resulted in a severe phenotype in the proband, and her brother with a late in life expression and a good response to diet and a hypotriglyceridemic treatment. The same mutation was detected in a 13-year-old daughter who to date is normotriglyceridemic. CONCLUSIONS—: We have identified a novel pathogenic mutation in CREB3L3 gene in a family with dominant hypertriglyceridemia with a variable pattern of penetrance.
Settore MED/09 - Medicina Interna
http://atvb.ahajournals.org/
Cefalù, A., Spina, R., Noto, D., Valenti, V., Ingrassia, V., Giammanco, A., et al. (2015). Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 35(12), 2694-2699 [10.1161/ATVBAHA.115.306170].
File in questo prodotto:
File Dimensione Formato  
ATVB2015306170 (1).pdf

Solo gestori archvio

Descrizione: Articolo
Dimensione 640.74 kB
Formato Adobe PDF
640.74 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/151391
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 15
social impact